InProTher is developing first-in-class immunotherapies against cancer and has pre-clinical proof of concept for broad and curative cancer therapy. Treated animals eliminate their tumors and become resistant to challenge from administered cancer cells. A combination with immune checkpoint inhibitors makes the effect complete in animal models. InProTher's research is based upon research by Associate Professor Peter Johannes Holst and colleagues and international collaborators.
| Website | http://www.inprother.com |
| Employees | 19 (1 on RocketReach) |
| Founded | 2018 |
| Phone | +45 51 75 62 83 |
| Technologies |
JavaScript
,
HTML
,
PHP
+10 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Cancer Immunotherapy, Cancer Therapy, Cancer Treatment, Immunotherapies, Cancer Research, Oncology, Preclinical Research, Drug Development, Immunology, Novel Therapies, Cell Therapy, Therapeutic Antibodies, Biotechnology, Pharmaceutical, Clinical Trials, Cancer Vaccines, Precision Medicine, Oncolytic Viruses |
| Competitors | Medtronic, Stryker, Amgen, Smith+Nephew, Integra LifeSciences, Acelity, Exactech, Actavis plc (now Allergan), LIFECELL LIMITED, BIOREP TECHNOLOGIES, INC. +38 more (view full list) |
Looking for a particular InProTher employee's phone or email?
InProTher Questions
1 people are employed at InProTher.
Top InProTher Employees
Related Companies
G2Crowd Trusted
300K+
Plugin Users
